You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) — Mesa Biotech said today that its PCR testing platform for point-of-care infectious disease testing has obtained CE marking in the EU.
The first available test in the EU market will be the company's Flu A/Flu B test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.